EFFECTIVENESS AND SAFETY OF BIOSIMILAR INFLIXIMAB (CT-P13) IN A REAL-LIFE SETTING IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS

被引：0
|
作者：
Codreanu, C. [1 ]
Sirova, K. [2 ]
Jarosova, K. [3 ]
Batalov, A. [4 ]
机构：
[1] Clin Ctr Rheumat Dis, Rheumatol, Bucharest, Romania
[2] Revmatol MUDr Klara Sirova Sro, Rheumatol, Ostrava, Czech Republic
[3] Inst Rheumatol, Rheumatol, Prague, Czech Republic
[4] Med Univ Plovdiv, MHAT Kaspela, Rheumatol, Plovdiv, Bulgaria
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.4409
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0165
引用
收藏
页码：489 / 489
页数：1
相关论文
共 50 条
  • [1] Assessment of effectiveness and safety of biosimilar infliximab (CT-P13) in a real-life setting for treatment of patients with active rheumatoid arthritis or ankylosing spondylitis
    Codreanu, Catalin
    Sirova, Klara
    Jarosova, Katerina
    Batalov, Anastas
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (10) : 1763 - 1769
  • [2] Effectiveness and Safety of CT-P13 (Biosimilar Reference Infliximab) in a Real-Life Setting in 151 Patients with Rheumatoid Arthritis and Ankylosing Spondylitis: A Mid-Term Interim Analysis
    Codreanu, Catalin
    Sirova, Klara
    Jarosova, Katerina
    Batalov, Anastas
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [3] Effectiveness and safety of biosimilar infliximab (CT-P13) in a real-life setting in patients with Crohn's disease or ulcerative colitis
    Gheorghe, Cristian
    Svoboda, Pavel
    Mateescu, Bogdan
    [J]. JOURNAL OF DRUG ASSESSMENT, 2019, 8 (01) : 129 - 134
  • [4] A 5-year Retrospective Analysis of Drug Survival, Safety, and Effectiveness of the Infliximab Biosimilar CT-P13 in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
    Tae-Hwan Kim
    Shin-Seok Lee
    Won Park
    Yeong Wook Song
    Chang-Hee Suh
    SooKyoung Kim
    Young Nam Lee
    Dae Hyun Yoo
    [J]. Clinical Drug Investigation, 2020, 40 : 541 - 553
  • [5] A 5-year Retrospective Analysis of Drug Survival, Safety, and Effectiveness of the Infliximab Biosimilar CT-P13 in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
    Kim, Tae-Hwan
    Lee, Shin-Seok
    Park, Won
    Song, Yeong Wook
    Suh, Chang-Hee
    Kim, SooKyoung
    Lee, Young Nam
    Yoo, Dae Hyun
    [J]. CLINICAL DRUG INVESTIGATION, 2020, 40 (06) : 541 - 553
  • [6] META-ANALYSIS OF THE SAFETY DATA BETWEEN INFLIXIMAB BIOSIMILAR (CT-P13) AND INNOVATOR INFLIXIMAB IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Park, W.
    Yoo, D. H.
    Suh, C. H.
    Shim, S. C.
    Lee, S. J.
    Lee, S. Y.
    Park, J. H.
    Bae, Y. M.
    Kim, S. H.
    Lee, S. G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1039 - 1039
  • [7] Year-two Follow-up Results of an Observational Study Conducted in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis Patients Treated with Infliximab Biosimilar CT-P13 in a Real-life Setting
    Fautrel, Bruno
    Assing, Maryse
    Mammar, Nadir
    Brault, Yves
    Marotte, Hubert
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2810 - 2812
  • [8] A RETROSPECTIVE ANALYSIS OF LONG TERM SAFETY UP TO FIVE YEARS OF INFLIXIMAB BIOSIMILAR CT-P13 IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Kim, Tae-Hwan
    Lee, Shin-Seok
    Park, Won
    Song, Yeong Wook
    Suh, Chang-Hee
    Kim, Sookyoung
    Lee, Youngnam
    Yoo, DaeHyun
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1159 - 1160
  • [9] Efficacy and Safety of CT-P13 (Infliximab Biosimilar) over Two Years in Patients with Ankylosing Spondylitis: Comparison Between Continuing with CT-P13 and Switching from Infliximab to CT-P13
    Park, Won
    Miranda, Pedro
    Brzosko, Marek
    Wiland, Piotr
    Gutierrez-Urena, Sergio
    Mikazane, Helena
    Lee, Yeon-Ah
    Smiyan, Svitlana
    Lim, Mie-Jin
    Kadinov, Vladimir
    Abud-Mendoza, Carlos
    Son, YoungKi
    Yoo, Dae-Hyun
    Braun, Juergen
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 (12): : 3326 - 3326
  • [10] Infliximab Biosimilar CT-P13 Observational Studies for Rheumatoid Arthritis, Inflammatory Bowel Diseases, and Ankylosing Spondylitis: Pooled Analysis of Long-Term Safety and Effectiveness
    Jae Hee Cheon
    Seongsu Nah
    Hyoun Woo Kang
    Yun Jeong Lim
    Sang-Hoon Lee
    Sang Joon Lee
    Sung Hyun Kim
    Na Hyun Jung
    Jeong Eun Park
    Yeo Jin Lee
    Da Bee Jeon
    Yeon Mi Lee
    Jong Min Kim
    Sung-Hwan Park
    [J]. Advances in Therapy, 2021, 38 : 4366 - 4387
12345